The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yankey, B. A., Rothenberg, R., Strasser, S. M., Ramsey-White, K., & Okosun, I. S. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317723212 · Cited by 48
RetractedNitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Self-citationIsolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Self-citationGaliègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Self-citationTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00379-8 · Cited by 900
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Triggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767
Endocannabinoid control of food intake and energy balance
Di Marzo, V., & Matias, I. (2005) · Nature Neuroscience · doi:10.1038/nn1457 · Cited by 743
Scheen, A. J., Finer, N., Hollander, P., Jensen, M. D., & Van Gaal, L. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 736
Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734
Self-citationATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Yvan-Charvet, L., Pagler, T., Gautier, E. L., Avagyan, S., Siry, R. L., Han, S., Welch, C. L., Wang, N., Randolph, G. J., Snoeck, H. W., et al. (2010) · Science · doi:10.1126/science.1189731 · Cited by 725
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Self-citationCannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571
Self-citationChronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 568
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Silvestri, C., & Di Marzo, V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.001 · Cited by 543
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity
Blüher, M., Engeli, S., Klöting, N., Berndt, J., Fasshauer, M., Bátkai, S., Pacher, P., Schön, M. R., Jordan, J., & Stumvoll, M. (2006) · Diabetes · doi:10.2337/db06-0812 · Cited by 530
Self-citationRajesh, M., Mukhopadhyay, P., Bátkai, S., Patel, V., Saito, K., Matsumoto, S., Kashiwaya, Y., Horváth, B., Mukhopadhyay, B., Becker, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.033 · Cited by 499
Self-citationHuestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473
Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.021 · Cited by 472
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A., Frossard, J.-L., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 472
Self-citationIs lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 414
Self-citationVarga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410
Self-citationSynthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2
Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 404
Nissen, S. E., Nicholls, S. J., Wolski, K., Rodés-Cabau, J., Cannon, C. P., Deanfield, J. E., Després, J.-P., Kastelein, J. J. P., Steinhubl, S. R., Kapadia, S., et al. (2008) · JAMA · doi:10.1001/jama.299.13.1547 · Cited by 403
Kozak, K. R., Rowlinson, S. W., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007088200 · Cited by 390
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
Self-citationCôté, M., Matias, I., Lemieux, I., Petrosino, S., Alméras, N., Després, J.-P., & Di Marzo, V (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803539 · Cited by 383
Bátkai, S., Járai, Z., Wagner, J. A., Goparaju, S. K., Varga, K., Liu, J., Wang, L., Mirshahi, F., Khanolkar, A. D., Makriyannis, A., et al. (2001) · Nature Medicine · doi:10.1038/89953 · Cited by 378
Self-citationProduction and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms13958 · Cited by 349
Self-citationFunctional CB1 cannabinoid receptors in human vascular endothelial cells
Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460835 · Cited by 333
Self-citationEndocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Bátkai, S., Pacher, P., Osei-Hyiaman, D., Radaeva, S., Liu, J., Harvey-White, J., Offertáler, L., Mackie, K., Rudd, M. A., Bukoski, R. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143230.23252.d2 · Cited by 322
Self-citation“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Adams, A. J., Banister, S. D., Irizarry, L., Trecki, J., Schwartz, M., & Gerona, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610300 · Cited by 320
Prescott, S. M., & Majerus, P. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33114-4 · Cited by 315
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Self-citationHohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 284
Self-citationA historical overview of chemical research on cannabinoids
Mechoulam, R., & Hanuš, L. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00184-5 · Cited by 282
Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin
Burdyga, G., Lal, S., Varro, A., Dimaline, R., Thompson, D. G., & Dockray, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5404-03.2004 · Cited by 280
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H., Dvir-Ginzberg, M., Rácz, I., Ulas, T., Imbeault, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4311 · Cited by 269
Topol, E. J., Bousser, M.-G., Fox, K. A., Creager, M. A., Despres, J.-P., Easton, J. D., Hamm, C. W., Montalescot, G., Steg, P. G., Pearson, T. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60935-x · Cited by 266
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., O’Sullivan, S. E., & Tan, G. D. (2016) · Diabetes Care · doi:10.2337/dc16-0650 · Cited by 262
An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant
Randall, M. D., Alexander, S. P. H., Bennett, T., Boyd, E. A., Fry, J. R., Gardiner, S. M., Kemp, P. A., Mcculloch, A. I., & Kendall, D. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1766 · Cited by 261
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 259
Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders
Jouanjus, E., Lapeyre‐Mestre, M., Micallef, J., & The French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP‐A) Working Group on Cannabis Complications* (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000638 · Cited by 253
Rajesh, M., Bátkai, S., Kechrid, M., Mukhopadhyay, P., Lee, W.-S., Horváth, B., Holovac, E., Cinar, R., Liaudet, L., Mackie, K., et al. (2012) · Diabetes · doi:10.2337/db11-0477 · Cited by 251
Self-citationMetabolism of endocannabinoids and related N‐acylethanolamines: Canonical and alternative pathways
Ueda, N., Tsuboi, K., & Uyama, T. (2013) · The FEBS Journal · doi:10.1111/febs.12152 · Cited by 234
Banister, S. D., Moir, M., Stuart, J., Kevin, R. C., Wood, K. E., Longworth, M., Wilkinson, S. M., Beinat, C., Buchanan, A. S., Glass, M., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00112 · Cited by 234
Han, K. H., Lim, S., Ryu, J., Lee, C.-W., Kim, Y., Kang, J.-H., Kang, S.-S., Ahn, Y. K., Park, C.-S., & Kim, J. J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp240 · Cited by 232
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle
Bonz, A., Laser, M., Küllmer, S., Kniesch, S., Babin-Ebell, J., Popp, V., Ertl, G., & Wagner, J. A. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00020 · Cited by 229
Simon, G. M., & Cravatt, B. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707807200 · Cited by 228
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
Dudok, B., Barna, L., Ledri, M., Szabó, S. I., Szabadits, E., Pintér, B., Woodhams, S. G., Henstridge, C. M., Balla, G. Y., Nyilas, R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3892 · Cited by 227
Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005) · Stroke · doi:10.1161/01.str.0000163083.59201.34 · Cited by 226
Cannabinoids in treatment-resistant epilepsy: A review
O'Connell, B. K., Gloss, D., & Devinsky, O. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.012 · Cited by 226
Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.
Murphy, T. D., Weidenbach, K. N., Houten, C. V., et al. (2013) · PubMed Central · Cited by 223
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
Hsu, K.-L., Tsuboi, K., Adibekian, A., Pugh, H., Masuda, K., & Cravatt, B. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1105 · Cited by 222
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Self-citationCannabidiol lowers incidence of diabetes in non-obese diabetic mice
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2006) · Autoimmunity · doi:10.1080/08916930500356674 · Cited by 215
Mukhopadhyay, P., Bátkai, S., Rajesh, M., Czifra, N., Harvey-White, J., Haskó, G., Zsengeller, Z., Gerard, N. P., Liaudet, L., Kunos, G., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.057 · Cited by 207
Self-citationLake, K. D., Compton, D. R., Varga, K., Martin, B. R., & Kunos, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36714-x · Cited by 201
Self-citationMukhopadhyay, P., Rajesh, M., Bátkai, S., Patel, V., Kashiwaya, Y., Liaudet, L., Evgenov, O. V., Mackie, K., Haskó, G., & Pacher, P. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp369 · Cited by 200
Self-citationDesprés, J.-P., Ross, R., Boka, G., Alméras, N., & Lemieux, I. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176362 · Cited by 200
Van Gaal, L., Pi-Sunyer, X., Després, J.-P., McCarthy, C., & Scheen, A. (2008) · Diabetes Care · doi:10.2337/dc08-s258 · Cited by 199
Sugamura, K., Sugiyama, S., Nozaki, T., Matsuzawa, Y., Izumiya, Y., Miyata, K., Nakayama, M., Kaikita, K., Obata, T., Takeya, M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.811992 · Cited by 196
Rajesh, M., Mukhopadhyay, P., Haskó, G., Huffman, J. W., Mackie, K., & Pacher, P. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707569 · Cited by 196
Self-citationCannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
Self-citationCB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M., Mach, F., & Steffens, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.014 · Cited by 182
Self-citationBiology of endocannabinoid synthesis system
Wang, J., & Ueda, N. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.002 · Cited by 180
Presence and regulation of the endocannabinoid system in human dendritic cells
Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J., & Di Marzo, V. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03078.x · Cited by 179
Mukamal, K. J., Maclure, M., Muller, J. E., & Mittleman, M. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.049 · Cited by 178
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Horváth, B., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.003 · Cited by 176
Self-citationHao, E., Mukhopadhyay, P., Cao, Z., Erdélyi, K., Holovac, E., Liaudet, L., Lee, W.-S., Haskó, G., Mechoulam, R., & Pacher, P. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00261 · Cited by 176
Self-citationMukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 173
Self-citationKim-Mitsuyama, S., Yamamoto, E., Tanaka, T., Zhan, Y., Izumi, Y., Izumiya, Y., Ioroi, T., Wanibuchi, H., & Iwao, H. (2005) · Stroke · doi:10.1161/01.str.0000163084.16505.e3 · Cited by 173
Huestis, M. A., Boyd, S. J., Heishman, S. J., Preston, K. L., Bonnet, D., Le Fur, G., & Gorelick, D. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0861-5 · Cited by 167
Cardiovascular Pharmacology of Cannabinoids
Pacher, P., Bátkai, S., & Kunos, G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_20 · Cited by 167
Self-citationAt the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
Montecucco, F., & Di Marzo, V. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.002 · Cited by 166
Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J. I., & Tuma, R. F. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600447 · Cited by 164
Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Mackie, K., & Pacher, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00712.x · Cited by 162
Self-citationMaccarrone, M., De Petrocellis, L., Bari, M., Fezza, F., Salvati, S., Di Marzo, V., & Finazzi-Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162
Role of the endocannabinoid system in diabetes and diabetic complications
Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 161
Self-citationCannabidiol arrests onset of autoimmune diabetes in NOD mice
Weiss, L., Zeira, M., Reich, S., Slavin, S., Raz, I., Mechoulam, R., & Gallily, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.029 · Cited by 160
The Biodisposition and Metabolism of Anandamide in Mice
Willoughby, K. A., Moore, S. F., Martin, B. R., & Ellis, E. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36812-0 · Cited by 159
Rumalla, K., Reddy, A. Y., & Mittal, M. K. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.066 · Cited by 159
Van Gaal, L. F., Scheen, A. J., Rissanen, A. M., Rössner, S., Hanotin, C., & Ziegler, O. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn076 · Cited by 156
Durst, R. Y., Danenberg, H. D., Gallily, R., Mechoulam, R., Meir, K., Grad, E., Beeri, R., Pugatsch, T., Tarsish, E., & Lotan, C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00098.2007 · Cited by 153
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Barutta, F., Corbelli, A., Mastrocola, R., Gambino, R., Marzo, V. D., Pinach, S., Rastaldi, M. P., Perin, P. C., & Gruden, G. (2010) · Diabetes · doi:10.2337/db09-1336 · Cited by 152
Metabolic Effects of Chronic Cannabis Smoking
Muniyappa, R., Sable, S., Ouwerkerk, R., Mari, A., Gharib, A. M., Walter, M. F., Courville, A. B., Hall, G., Chen, K. Y., Volkow, N. D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2303 · Cited by 152
Self-citationWang, X., Derakhshandeh, R., Liu, J., Narayan, S., Nabavizadeh, P., Le, S., Danforth, O. M., Pinnamaneni, K., Rodriguez, H. J., Luu, E., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003858 · Cited by 151
Synthetic cannabinoid drug use as a cause or contributory cause of death
Labay, L. M., Caruso, J. L., Gilson, T. P., Phipps, R., Knight, L. D., Lemos, N. P., McIntyre, I. M., Stoppacher, R., Tormos, L. M., Wiens, A. L., et al. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2015.12.046 · Cited by 149
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
Wagner, J. A., Hu, K., Bauersachs, J. K., Karcher, J. C., Wiesler, M., Goparaju, S. K., Kunos, G., & Ertl, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01671-0 · Cited by 148
Self-citationIs the cardiovascular system a therapeutic target for cannabidiol?
Stanley, C. P., Hind, W. H., & O’Sullivan, S. E. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04351.x · Cited by 147
Rajavashisth, T. B., Shaheen, M. A., Norris, K. C., Pan, D., Sinha, S. K., Ortega, J. P. M., & Friedman, T. C. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000494 · Cited by 147
Quercioli, A., Pataky, Z., Vincenti, G. M., Makoundou, V., Marzo, V. D., Montecucco, F., Carballo, S., Thomas, A., Staub, C., Steffens, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr029 · Cited by 146
Self-citationOveractive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
Jourdan, T., Szanda, G., Rosenberg, A. Z., Tam, J., Earley, B. J., Godlewski, G., Çınar, R., Liu, Z., Liu, J., Ju, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419901111 · Cited by 145
Self-citationSugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., & Waku, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8187 · Cited by 144
Targeting cannabinoid receptor CB2in cardiovascular disorders: promises and controversies
Steffens, S., & Pacher, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02042.x · Cited by 137
Self-citationJouanjus, É., Raymond, V., Lapeyre‐Mestre, M., & Wolff, V. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0663-0 · Cited by 137
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa
Radwan, M. M., ElSohly, M. A., El‐Alfy, A. T., Ahmed, S. A., Slade, D., Husni, A. S., Manly, S. P., Wilson, L., Seale, S., Cutler, S. J., et al. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00065 · Cited by 133
Filippo, C. D., Rossi, F., Rossi, S., & D’Amico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 132
Kunos, G., & Tam, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01352.x · Cited by 127
Self-citationZhang, M., Adler, M. W., Abood, M. E., Ganea, D., Jallo, J., & Tuma, R. F. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.03.005 · Cited by 127
Dol-Gleizes, F., Paumelle, R., Visentin, V., Marés, A.-M., Desitter, P., Hennuyer, N., Gilde, A. J., Staels, B., Schaeffer, P., & Bono, F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168757 · Cited by 123
Pacher, P., Mukhopadhyay, P., Rajesh, M., Godlewski, G., Bátkai, S., & Kunos, G. (2008) · Hypertension · doi:10.1161/hypertensionaha.105.063651 · Cited by 123
Self-citationZhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Ganea, D., & Tuma, R. F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.022 · Cited by 121
Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Hillard, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740054 · Cited by 120
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
Pacher, P., Bátkai, S., & Kunos, G. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.064824 · Cited by 119
Self-citationBátkai, S., Mukhopadhyay, P., Harvey-White, J. D., Kechrid, R., Pacher, P., & Kunos, G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2007 · Cited by 118
Self-citationReis, J. P., Auer, R., Bancks, M. P., Goff, D. C., Lewis, C. E., Pletcher, M. J., Rana, J. S., Shikany, J. M., & Sidney, S. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303654 · Cited by 117
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity
Fouad, A. A., Albuali, W. H., Al-Mulhim, A. S., & Jresat, I. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.04.018 · Cited by 116
Law, R., Schier, J. G., Martin, C. A., Chang, A. S., & Wolkin, A. F. (2015) · PubMed Central · Cited by 116
Wargent, E. T., Zaibi, M. S., Silvestri, C., Hislop, D. C., Stocker, C. J., Stott, C. G., Guy, G. W., Duncan, M., Marzo, V. D., & Cawthorne, M. A. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.9 · Cited by 115
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor
Delgado‐Peraza, F., Ahn, K. H., Nogueras‐Ortiz, C. J., Mungrue, I. N., Mackie, K., Kendall, D. A., & Yudowski, G. A. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103176 · Cited by 115
Cardiovascular actions of cannabinoids and their generation during shock
Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 111
Self-citationHeavy cannabis users at elevated risk of stroke: evidence from a general population survey
Hemachandra, D., McKetin, R., Cherbuin, N., & Anstey, K. J. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12477 · Cited by 109
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
Silvestri, C., Paris, D., Martella, A., Melck, D. J., Guadagnino, I., Cawthorne, M., Motta, A., & Marzo, V. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.001 · Cited by 108
Tiyerili, V., Zimmer, S., Jung, S., Wassmann, K., Naehle, C. P., Lütjohann, D., Zimmer, A., Nickenig, G., & Waßmann, S. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0090-7 · Cited by 107
Ceprián, M., Jiménez-Sánchez, L., Vargas, C. A., Barata, L., Hind, W. H., & Martínez-Orgado, J. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.017 · Cited by 107
Vascular targets for cannabinoids: animal and human studies
Stanley, C. P., & O’Sullivan, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12560 · Cited by 106
Hayakawa, K., Mishima, K., Irie, K., Hazekawa, M., Mishima, S., Fujioka, M., Orito, K., Egashira, N., Katsurabayashi, S., Takasaki, K., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.040 · Cited by 105
Slavić, S., Lauer, D., Sommerfeld, M., Kemnitz, U. R., Grzesiak, A., Trappiel, M., Thöne‐Reineke, C., Baulmann, J., Paulis, L., Kappert, K., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1034-0 · Cited by 105
Sudden unexpected death under acute influence of cannabis
Hartung, B., Kauferstein, S., Ritz‐Timme, S., & Daldrup, T. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.02.001 · Cited by 102
Marijuana use and long-term mortality among survivors of acute myocardial infarction
Frost, L. E., Mostofsky, E., Rosenbloom, J. I., Mukamal, K. J., & Mittleman, M. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.11.007 · Cited by 101
Niederhoffer, N., Schmid, K., & Szabó, B. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0755-y · Cited by 100
Strokes are possible complications of cannabinoids use
Wolff, V., & Jouanjus, É. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.01.031 · Cited by 98
Kalla, A., Krishnamoorthy, P. M., Gopalakrishnan, A., & Figueredo, V. M. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000681 · Cited by 98
K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure
Patton, A. L., Chimalakonda, K. C., Moran, C. L., McCain, K. R., Radominska-p, A., James, L. P., Kokes, C. P., & Moran, J. H. (2013) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12216 · Cited by 96
Yeshurun, M., Shpilberg, O., Herscovici, C., Shargian, L., Dreyer, J., Peck, A., Israeli, M., Levy-Assaraf, M., Gruenewald, T., Mechoulam, R., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.05.018 · Cited by 95
Endocannabinoids in cerebrovascular regulation
Benyó, Z., Ruisanchez, É., Leszl-Ishiguro, M., Sándor, P., & Pacher, P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00571.2015 · Cited by 94
Self-citationEnglund, A., Atakan, Z., Kralj, A., Tunstall, N., Murray, R. M., & Morrison, P. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115615104 · Cited by 94
Zhao, Y., Yuan, Z., Liu, Y., Xue, J., Tian, Y., Liu, W., Zhang, W., Shen, Y., Xu, W., Liang, X., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d2644d · Cited by 92
Yang, Y., Liu, H., Nam, S. W., Kunos, G., & Lee, S. S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.011 · Cited by 92
Self-citationLee, W.-S., Erdélyi, K., Mátyás, C., Mukhopadhyay, P., Varga, Z. V., Liaudet, L., Haskó, G., Čiháková, D., Mechoulam, R., & Pacher, P. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00007 · Cited by 89
Self-citationHayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 87
Gorelick, D. A., Goodwin, R. S., Schwilke, E. W., Schwope, D. M., Darwin, W. D., Kelly, D. L., McMahon, R. P., Liu, F., Ortemann, C., BONNET, D., et al. (2012) · Journal of Analytical Toxicology · doi:10.1093/jat/bks081 · Cited by 87
Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Liu, J., Harvey-White, J., Brassai, A., Járai, Z., Cravatt, B. F., & Kunos, G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00107.2005 · Cited by 86
Self-citationIs recent cannabis use associated with acute coronary syndromes? An illustrative case series
Casier, I., Vanduynhoven, P., Haine, S. E. F., Vrints, C. J. M., & Jorens, P. G. (2014) · Acta cardiologica. Supplementum · doi:10.1080/ac.69.2.3017293 · Cited by 83
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Mukhopadhyay, P., Horváth, B., Rajesh, M., Matsumoto, S., Saito, K., Bátkai, S., Patel, V., Tanchian, G., Gao, R. Y., Cravatt, B. F., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.002 · Cited by 83
Self-citationA Unique Case of Cardiac Arrest following K2 Abuse
Ibrahim, S., Al-Saffar, F. I., & Wannenburg, T. (2014) · Case Reports in Cardiology · doi:10.1155/2014/120607 · Cited by 83
Bedi, G., Cooper, Z. D., & Haney, M. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00427.x · Cited by 83
Coronary Vasomotor Control in Obesity and Morbid Obesity
Quercioli, A., Pataky, Z., Montecucco, F., Carballo, S., Thomas, A., Staub, C., Marzo, V. D., Vincenti, G. M., Ambrosio, G., Ratib, O. M., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.01.020 · Cited by 81
Self-citation“Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
Piscitelli, F., & Marzo, V. D. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300015x · Cited by 81
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke
Falkstedt, D., Wolff, V., Allebeck, P., Hemmingsson, T., & Danielsson, A. (2016) · Stroke · doi:10.1161/strokeaha.116.015565 · Cited by 81
Anandamide activates human platelets through a pathway independent of the arachidonate cascade
Maccarrone, M., Bari, M., Menichelli, A., Principe, D. D., & Finazzi‐Agrò, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00308-7 · Cited by 79
Chiurchiù, V., Lanuti, M., Catanzaro, G., Fezza, F., Rapino, C., & Maccarrone, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.042 · Cited by 77
Cannabis-associated Myocardial Infarction in a Young Man with Normal Coronary Arteries
Hodcroft, C. J., Rossiter, M. C., & Buch, A. N. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.11.077 · Cited by 77
Montecucco, F., Matias, I., Lenglet, S., Petrosino, S., Burger, F., Pelli, G., Braunersreuther, V., Mach, F., Steffens, S., & Marzo, V. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.040 · Cited by 77
Self-citationCannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
Rajesh, M., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.159 · Cited by 71
Self-citationLi, Q., Wang, F., Zhang, Y.-M., Zhou, J., & Zhang, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350088 · Cited by 71
Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage
Rumalla, K., Reddy, A. Y., & Mittal, M. K. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.10.019 · Cited by 71
Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.
(2013) · PubMed · Cited by 71
Cholesterol Efflux: A Novel Regulator of Myelopoiesis and Atherogenesis
Tall, A. R., Yvan‐Charvet, L., Westerterp, M., & Murphy, A. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300134 · Cited by 70
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
Lehmann, C., Fisher, N. B., Tugwell, B. D., Szczesniak, A. M., Kelly, M. E. M., & Zhou, J. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168021 · Cited by 70
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo
Hoyer, F. F., Steinmetz, M., Zimmer, S., Becker, A., Lütjohann, D., Buchalla, R., Zimmer, A., & Nickenig, G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.008 · Cited by 69
Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Huestis, M. A. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.11.006 · Cited by 68
Jiang, L., Pu, J., Han, Z.-H., Hu, L.-H., & He, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn344 · Cited by 68
Cannabinoid-2 Receptor Activation Protects Against Infarct and Ischemia–Reperfusion Heart Injury
Wang, P., Jiang, L.-S., Bu, J., Huang, X.-J., Song, W., Du, Y.-P., & He, B. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182418997 · Cited by 67
Kaskie, B. P., Ayyagari, P., Milavetz, G., Shane, D. M., & Arora, K. (2017) · The Gerontologist · doi:10.1093/geront/gnw166 · Cited by 67
Chouinard, F., Lefebvre, J. S., Navarro, P., Bouchard, L., Ferland, C., Lalancette–Hébert, M., Marsolais, D., Laviolette, M., & Flamand, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002853 · Cited by 62
Toxic Effects of Marijuana on the Cardiovascular System
Pratap, B., & Korniyenko, A. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9150-y · Cited by 60
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Bátkai, S., & Pacher, P. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.003 · Cited by 60
Self-citationCannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism
Hayakawa, K., Mishima, K., Abe, K., Hasebe, N., Takamatsu, F., Yasuda, H., Ikeda, T., Inui, K., Egashira, N., Iwasaki, K., et al. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00016 · Cited by 60
Zhao, Y., Liu, Y., Zhang, W., Xue, J., Wu, Y., Xu, W., Liang, X., Chen, T., Kishimoto, C., & Yuan, Z. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.027 · Cited by 58
O’Leary, D. H., Reuwer, A. Q., Nissen, S. E., Després, J., Deanfield, J. E., Brown, M. W., Zhou, R., Zabbatino, S., Job, B., Kastelein, J. J. P., et al. (2011) · Heart · doi:10.1136/hrt.2011.223446 · Cited by 58
Lenglet, S., Thomas, A., Soehnlein, O., Montecucco, F., Burger, F., Pelli, G., Galan, K., Cravatt, B. F., Staub, C., & Steffens, S. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300275 · Cited by 58
Self-citationEndocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction
Wenzel, D., Matthey, M., Bîndilă, L., Lerner, R., Lutz, B., Zimmer, A., & Fleischmann, B. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308130110 · Cited by 56
Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project
Hermanns‐Clausen, M., Kithinji, J., Spehl, M. S., Angerer, V., Franz, F., Eyer, F., & Auwärter, V. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1936 · Cited by 56
Marijuana and Second-Degree AV Block
Akins, D. E., & Awdeh, M. R. (1981) · Southern Medical Journal · doi:10.1097/00007611-198103000-00035 · Cited by 55
Acute inferior myocardial infarction due to cannabis smoking in a young man
Kocabay, G., Yildiz, M., Duran, N. E., & Özkan, M. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832bcfbe · Cited by 54
Monte, A. A., Calello, D. P., Gerona, R. R. L., Hamad, E., Campleman, S. L., Brent, J., Wax, P. M., & Carlson, R. G. (2017) · Journal of Medical Toxicology · doi:10.1007/s13181-017-0605-9 · Cited by 54
Alshaarawy, O., & Anthony, J. C. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.017 · Cited by 53
Feng, Y., Chen, F., Yin, T., Xia, Q., Liu, Y., Huang, G., Zhang, J., Oyen, R., & Ni, Y. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000287 · Cited by 52
Teenage Cardiac Arrest Following Abuse of Synthetic Cannabis
Davis, C., & Boddington, D. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.04.176 · Cited by 50
An ultra-low dose of tetrahydrocannabinol provides cardioprotection
Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D. J., Shainberg, A., & Sarne, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.014 · Cited by 50
Cannabis: a trigger for acute myocardial infarction? A case report
Cappelli, F., Lazzeri, C., Gensini, G. F., & Valente, S. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f2cd0d · Cited by 50
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes
Jourdan, T., Szanda, G., Çınar, R., Godlewski, G., Holovac, D. J., Park, J. K., Nicoloro, S. M. C., Shen, Y., Liu, J., Rosenberg, A. Z., et al. (2017) · Diabetes · doi:10.2337/db16-1199 · Cited by 50
Self-citationBaye, T. M., Zhang, Y., Smith, E., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1647 · Cited by 48
Klumpers, L. E., Roy, C., Ferron‐Brady, G., Turpault, S., Poitiers, F., Pinquier, J., van Hasselt, J. G. C., Zuurman, L., Erwich, F. A. S., & van Gerven, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12071 · Cited by 46
Molica, F., Burger, F., Thomas, A., Staub, C., Tailleux, A., Staels, B., Pelli, G., Zimmer, A., Cravatt, B. F., Matter, C. M., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035147 · Cited by 44
Self-citationZarifi, C., & Vyas, S. (2017) · The Permanente Journal · doi:10.7812/tpp/16-160 · Cited by 43
Hayakawa, K., Irie, K., Sano, K., Watanabe, T., Higuchi, S., Enoki, M., Nakano, T., Harada, K., Ishikane, S., Ikeda, T., et al. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1538 · Cited by 42
Baranchuk, A. M., Johri, A. M., Simpson, C. S., Methot, M., & Redfearn, D. (2008) · Cases Journal · doi:10.1186/1757-1626-1-373 · Cited by 41
Cited by
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
Page, R. L., Allen, L. A., Kloner, R. A., Carriker, C. R., Martel, C., Morris, A. A., Piano, M. R., Rana, J. S., Saucedo, J. F., & On behalf of the American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care and Outcomes Research (2020) · Circulation · doi:10.1161/cir.0000000000000883 · Cited by 260
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Metadata
- Authors
- Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G.
- Venue
- Nature Reviews Cardiology
- Published
- 2017-09-14
- Volume
- 15
- Issue
- 3
- Pages
- 151-166
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2754378617
- Cited by
- 439
- References
- 229
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.